AbbVie
ABBV
ABBV
4,018 hedge funds and large institutions have $285B invested in AbbVie in 2026 Q1 according to their latest regulatory filings, with 185 funds opening new positions, 1,700 increasing their positions, 1,676 reducing their positions, and 180 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $301B → $285B (-$16.5B)
11% less call options, than puts
Call options by funds: $2.21B | Put options by funds: $2.5B
13% less funds holding in top 10
Funds holding in top 10: 198 → 173 (-25)
Holders
4,018
Holding in Top 10
173
Calls
$2.21B
Puts
$2.5B
Top Buyers
| 1 | +$1.88B | |
| 2 | +$1.3B | |
| 3 | +$965M | |
| 4 |
DAM
Diamant Asset Management
Ridgefield,
Connecticut
|
+$811M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$782M |
Top Sellers
| 1 | -$2.71B | |
| 2 | -$1.78B | |
| 3 | -$1.74B | |
| 4 |
CRM
Cardano Risk Management
Rotterdam,
Netherlands
|
-$1.09B |
| 5 |
Corient Private Wealth
Miami,
Florida
|
-$596M |
